Omada Health Statistics
Total Valuation
Omada Health has a market cap or net worth of $1.52 billion. The enterprise value is $1.33 billion.
Important Dates
The next confirmed earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Omada Health has 57.57 million shares outstanding. The number of shares has increased by 69.46% in one year.
| Current Share Class | 57.57M |
| Shares Outstanding | 57.57M |
| Shares Change (YoY) | +69.46% |
| Shares Change (QoQ) | +166.61% |
| Owned by Insiders (%) | 1.70% |
| Owned by Institutions (%) | 47.88% |
| Float | 41.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.42 |
| Forward PS | 5.72 |
| PB Ratio | 6.92 |
| P/TBV Ratio | 7.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.68, with a Debt / Equity ratio of 0.14.
| Current Ratio | 4.68 |
| Quick Ratio | 4.44 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -11.58% |
| Revenue Per Employee | $247,146 |
| Profits Per Employee | -$37,968 |
| Employee Count | 849 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 23.26 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 71.09 |
| Average Volume (20 Days) | 323,297 |
Short Selling Information
The latest short interest is 2.27 million, so 3.94% of the outstanding shares have been sold short.
| Short Interest | 2.27M |
| Short Previous Month | 2.57M |
| Short % of Shares Out | 3.94% |
| Short % of Float | 5.46% |
| Short Ratio (days to cover) | 0.31 |
Income Statement
In the last 12 months, Omada Health had revenue of $209.83 million and -$32.24 million in losses. Loss per share was -$2.81.
| Revenue | 209.83M |
| Gross Profit | 132.90M |
| Operating Income | -28.36M |
| Pretax Income | -32.24M |
| Net Income | -32.24M |
| EBITDA | -23.17M |
| EBIT | -28.36M |
| Loss Per Share | -$2.81 |
Full Income Statement Balance Sheet
The company has $223.15 million in cash and $29.97 million in debt, giving a net cash position of $193.18 million or $3.36 per share.
| Cash & Cash Equivalents | 223.15M |
| Total Debt | 29.97M |
| Net Cash | 193.18M |
| Net Cash Per Share | $3.36 |
| Equity (Book Value) | 214.21M |
| Book Value Per Share | 3.74 |
| Working Capital | 213.12M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$18.69 million and capital expenditures -$846,000, giving a free cash flow of -$19.54 million.
| Operating Cash Flow | -18.69M |
| Capital Expenditures | -846,000 |
| Free Cash Flow | -19.54M |
| FCF Per Share | -$0.34 |
Full Cash Flow Statement Margins
Gross margin is 63.34%, with operating and profit margins of -13.52% and -15.36%.
| Gross Margin | 63.34% |
| Operating Margin | -13.52% |
| Pretax Margin | -15.36% |
| Profit Margin | -15.36% |
| EBITDA Margin | -11.04% |
| EBIT Margin | -13.52% |
| FCF Margin | n/a |
Dividends & Yields
Omada Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -69.46% |
| Shareholder Yield | -69.46% |
| Earnings Yield | -2.12% |
| FCF Yield | -1.28% |
Analyst Forecast
The average price target for Omada Health is $25.43, which is -3.75% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.43 |
| Price Target Difference | -3.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omada Health has an Altman Z-Score of 5.76 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.76 |
| Piotroski F-Score | 2 |